ARCHIVES

FDA says new tools needed to speed therapeutics development.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991

Tom Curran Becomes AACR President, Hong Is President-Elect; Attendance 13,000.

April 14, 2000

HHS News: Leavitt Confirmed As HHS Secretary.

January 28, 2005

NCI-Approved Clinical Trials

December 29, 2006